Send the following on WhatsApp
Continue to Chathttps://de.marketscreener.com/kurs/aktie/IKENA-ONCOLOGY-INC-120405762/news/Ikena-Oncology-Inc-teilt-erste-positive-und-differenzierte-Dosis-Eskalationsdaten-der-Phase-I-Stud-45286187/?utm_source=whatsapp&utm_medium=social&utm_campaign=share